Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2014


3rd Annual Clinical Outsourcing Asia Congress

27 Feb 2014 - 28 Feb 2014 - Shanghai, China



Bookmark and Share


Oxford Global Conferences are proud to present the 4th Annual Pharma R&D Asia Congress to be held on the 27th & 28th February 2014 in Shanghai, China.

The booming growth of research and development activities in Asia and Asia Pacific regions has advanced the opportunity for business success. Industry leaders believe that the Asian market will overtake the US by 2020. Our conference will bring together over 150 industry leaders to discuss the potential and future of the R&D industry. Our exclusive networking sessions will offer opportunities to meet with potential partners and form unique business relationships. 

Expert speakers will discuss strategies to advance research and development activities in Asia. They will offer insights into the importance of collaborations between eastern and western countries for advancing global drug development. Topics will also cover methods to choose correct outsourcing partners for business needs, attaining successful mergers and acquisitions and opportunities for multi-national companies in emerging markets.

Confirmed Speakers Include:

Yariv Hefez, VP, Merck, Switzerland 

Beverly Lui, Director, Amgen, China

Jian Li, Director, Global R&D Sanofi, China

Yuan-Hua Ding, Senior Director, Pfizer Worldwide R&D, USA

Simon McErlane, Senior Medical, Takeda Development Center Asia, Singapore


Contact Freda Shi today to download the agenda and for attendance information on f.shi@oxfordglobalasia.com or call +65 6570 2208 



Further information
Scientific News
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Early Antiretroviral Therapy Prevents Non-AIDS Outcomes in HIV-infected People
NIH-supported findings illustrate manifold benefit of therapy.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!